|
Volumn 302, Issue 2, 2014, Pages 889-894
|
Single vial formulation for theranostic radiopharmaceutical preparation
|
Author keywords
177Lu DOTATATE; 68Ga DOTATATE; DOTATATE formulation; PRRT; Theranostic
|
Indexed keywords
4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID;
GALLIUM 68;
LUTETIUM 177;
SOMATOSTATIN DERIVATIVE;
TETRAXETAN OCTREOTIDE GALLIUM GA 68;
TETRAXETAN OCTREOTIDE LUTETIUM LU 177;
TETRAXETAN OCTREOTIDE [3 THREONINE] GALLIUM GA 68;
TETRAXETAN OCTREOTIDE [3 THREONINE] LUTETIUM LU 177;
TETRAXETAN OCTREOTIDE [3 TYROSINE] GALLIUM GA 68;
TETRAXETAN OCTREOTIDE [3 TYROSINE] LUTETIUM LU 177;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
COMPLEX FORMATION;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG FORMULATION;
DRUG STRUCTURE;
ELUTION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HYDROPHILICITY;
ISOTOPE LABELING;
LAMINAR FLOW;
MOLECULAR IMAGING;
MOUSE;
NEUROENDOCRINE TUMOR;
NONHUMAN;
PAPER CHROMATOGRAPHY;
POSITRON EMISSION TOMOGRAPHY;
RADIOISOTOPE THERAPY;
|
EID: 84910131427
PISSN: 02365731
EISSN: 15882780
Source Type: Journal
DOI: 10.1007/s10967-014-3308-6 Document Type: Article |
Times cited : (7)
|
References (8)
|